Protective prostaglandins for use in conjunction with chemothera

Details Protective prostaglandins for use in conjunction with chemothera Protective prostaglandins for use in conjunction with chemothera

1995-05-11

1997-02-25

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514573, A61K 31215, A61K 3119, A61K 31557

Patent

active

056059310

ABSTRACT:
Prostaglandins of the PGE type can be administered in a therapeutically effective amount to protect tissue from injury resulting from chemotherapeutic agents by administering the PGE-type prostaglandin prior to administration of the chemotherapeutic agent.

REFERENCES:
patent: 4097603 (1978-06-01), Robert
patent: 5324746 (1994-06-01), McKee et al.
CA 76:364, Franks et al., 1971.
Potten, et al. "Hair Medullary Cell Counts--a simple and sensitive indicator of radiation exposure." Int. J. Radiat. Biol., 57, No. 1:13-21 (1990).
Jimenez, et al. "Biomedicine--Hair-Raising Adjunct for Chemotherapy." Science News, vol. 141:60 (1992).
Hussein, et al. "Protection from Chemotherapy-Induced Alopecia in a Rat Model." Science, vol. 249:1564-1566 (1990).
Jimenez, et al. "Protective from 1-B-D-Arabinofuranosylcytosine-Induced Alopecia by Epidermal Growth Factor." Cancer Research, vol. 52:413-415 (1992).
Torsher, et al. "Misoprostal Therapy Following Trinitrobenzene Sulfonic Acid-Induced Colitis-Accelerates Healing." CA, 116(23):228896W (1992).
Glover, et al. "Clinical Trials of WR-2721 Prior to Alkylating Agent Chemotherapy and Radiotherapy." Pharmac. Ther., vol. 39:3-7 (1988).

Affiliated with

Also associated with

Rating

Protective prostaglandins for use in conjunction with chemothera does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protective prostaglandins for use in conjunction with chemothera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protective prostaglandins for use in conjunction with chemothera will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1974342